BlackRock
STTK icon

BlackRock’s Shattuck Labs STTK Stock Holding History

BlackRock’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.3M Buy
3,935,810
+3,425,004
+671% +$21.4M ﹤0.01% 3066
2026
Q1 		$3.28M Buy
510,806
+92,277
+22% +$438K ﹤0.01% 3986
2025
Q4 		$1.53M Buy
418,529
+7,237
+2% +$17.3K ﹤0.01% 4192
2025
Q3 		$983K Sell
411,292
-470,096
-53% -$575K ﹤0.01% 4289
2025
Q2 		$698K Sell
881,388
-1,722,249
-66% -$1.67M ﹤0.01% 4364
2025
Q1 		$2.47M Sell
2,603,637
-35,481
-1% -$43.7K ﹤0.01% 3923
2024
Q4 		$3.19M Buy
2,639,118
+25,824
+1% +$32K ﹤0.01% 3896
2024
Q3 		$9.12M Buy
2,613,294
+138,817
+6% +$517K ﹤0.01% 3457
2024
Q2 		$9.55M Buy
2,474,477
+1,944,964
+367% +$15.8M ﹤0.01% 3409
2024
Q1 		$4.73M Buy
529,513
+38,686
+8% +$354K ﹤0.01% 3691
2023
Q4 		$3.5M Sell
490,827
-3,295
-0.7% -$8.99K ﹤0.01% 3837
2023
Q3 		$751K Sell
494,122
-24,533
-5% -$56K ﹤0.01% 4320
2023
Q2 		$1.62M Buy
518,655
+13,985
+3% +$40.6K ﹤0.01% 4142
2023
Q1 		$1.48M Buy
504,670
+1,053
+0.2% +$3.72K ﹤0.01% 4189
2022
Q4 		$1.16M Sell
503,617
-250,614
-33% -$628K ﹤0.01% 4363
2022
Q3 		$2.04M Sell
754,231
-28,309
-4% -$106K ﹤0.01% 4189
2022
Q2 		$3.18M Sell
782,540
-1,399,247
-64% -$5.07M ﹤0.01% 4026
2022
Q1 		$9.29M Sell
2,181,787
-28,032
-1% -$159K ﹤0.01% 3615
2021
Q4 		$18.8M Buy
2,209,819
+390,036
+21% +$5.37M ﹤0.01% 3311
2021
Q3 		$37.1M Buy
1,819,783
+78,441
+5% +$1.68M ﹤0.01% 2860
2021
Q2 		$50.5M Buy
1,741,342
+857,444
+97% +$25.1M ﹤0.01% 2698
2021
Q1 		$25.8M Buy
883,898
+23,725
+3% +$997K ﹤0.01% 3043
2020
Q4 		$45.1M Buy
+860,173
New +$27.6M ﹤0.01% 2539

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock's STTK Position: Q2 2026 in Review

BlackRock increased its Shattuck Labs (STTK) stake by 671% in Q2 2026, buying an estimated $21.4M and bringing the position to 3,935,810 shares worth $27.3M. The position accounts for ﹤0.01% of the portfolio, ranked #3066.

BlackRock first reported a position in STTK in Q4 2020 and has held it in 23 quarters since. The position peaked at $50.5M in Q2 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • BlackRock held 3,935,810 shares of Shattuck Labs worth $27.3M as of Q2 2026.
  • BlackRock bought 3,425,004 Shattuck Labs shares in Q2 2026, an estimated $21.4M.
  • Shattuck Labs made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3066 holding.
  • BlackRock first reported a position in Shattuck Labs in Q4 2020 and has held it in 23 quarters since.
  • BlackRock's Shattuck Labs position peaked at $50.5M in Q2 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.